BG60743B1 - Енантомери,/-/-циматерол и техните лекарствени препарати или стимулатори и метод за отделяне на енантомери от циматерол - Google Patents

Енантомери,/-/-циматерол и техните лекарствени препарати или стимулатори и метод за отделяне на енантомери от циматерол Download PDF

Info

Publication number
BG60743B1
BG60743B1 BG94342A BG9434291A BG60743B1 BG 60743 B1 BG60743 B1 BG 60743B1 BG 94342 A BG94342 A BG 94342A BG 9434291 A BG9434291 A BG 9434291A BG 60743 B1 BG60743 B1 BG 60743B1
Authority
BG
Bulgaria
Prior art keywords
tartaric acid
ethanol
acid
isopropylamino
cyano
Prior art date
Application number
BG94342A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG94342A (en
Inventor
Wolfgang Resemann
Adolf Duerr
Guenther Engelhardt
John Quirke
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of BG94342A publication Critical patent/BG94342A/xx
Publication of BG60743B1 publication Critical patent/BG60743B1/bg

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/111Aromatic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Birds (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG94342A 1990-05-04 1991-05-03 Енантомери,/-/-циматерол и техните лекарствени препарати или стимулатори и метод за отделяне на енантомери от циматерол BG60743B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014252A DE4014252A1 (de) 1990-05-04 1990-05-04 Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Publications (2)

Publication Number Publication Date
BG94342A BG94342A (en) 1994-06-30
BG60743B1 true BG60743B1 (bg) 1996-02-29

Family

ID=6405664

Family Applications (1)

Application Number Title Priority Date Filing Date
BG94342A BG60743B1 (bg) 1990-05-04 1991-05-03 Енантомери,/-/-циматерол и техните лекарствени препарати или стимулатори и метод за отделяне на енантомери от циматерол

Country Status (27)

Country Link
US (4) US5248695A (cs)
EP (2) EP0455155B1 (cs)
JP (1) JP2944777B2 (cs)
KR (1) KR0183024B1 (cs)
AR (1) AR247728A1 (cs)
AT (2) ATE158277T1 (cs)
AU (1) AU645313B2 (cs)
BG (1) BG60743B1 (cs)
CA (1) CA2041818C (cs)
CZ (1) CZ286389B6 (cs)
DE (3) DE4014252A1 (cs)
DK (2) DK0455155T3 (cs)
ES (2) ES2109412T3 (cs)
FI (1) FI109600B (cs)
GR (2) GR3017064T3 (cs)
HU (1) HU214335B (cs)
ID (1) ID966B (cs)
IE (2) IE69017B1 (cs)
IL (1) IL98030A (cs)
NO (1) NO174803B (cs)
NZ (1) NZ238032A (cs)
PT (1) PT97544B (cs)
RU (1) RU2002737C1 (cs)
SG (1) SG45439A1 (cs)
SK (1) SK279258B6 (cs)
TW (1) TW197415B (cs)
ZA (1) ZA913337B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
EP0892639A4 (en) * 1996-01-29 1999-06-09 Savor Evelyn PROCESS FOR THE TREATMENT OF UNWANTED UTERINE CONTRACTIONS USING OPTICALLY PURE R OR RR ISOMERS OF AGONIST -g (b) -2 ADRENERGIC AGONISTS
WO1998048810A1 (en) 1997-04-30 1998-11-05 Bridge Pharma, Inc. Composition and methods using an eutomer
EP1787529A3 (en) * 1997-04-30 2009-11-18 Courage Corporation Pty Ltd. Composition and methods using an eutomer
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
RU2201420C2 (ru) * 1998-11-03 2003-03-27 Новартис Аг Нитрилы дипептидов
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
EE200200602A (et) * 2000-04-27 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pikatoimelised beetamimeetikumid, meetod nende valmistamiseks ja nende kasutamine ravimitena
US20030162459A1 (en) * 2002-02-27 2003-08-28 Osbon Robert Lindsay Method for producing a nonwoven fabric with enhanced characteristics
US20040235922A1 (en) * 2003-05-15 2004-11-25 Baile Clifton A. Compositions and methods for inducing adipose tissue cell death
PL1663197T3 (pl) * 2003-09-09 2008-09-30 Biogen Idec Int Gmbh Zastosowanie pochodnych kwasu fumarowego do leczenia niewydolności serca oraz astmy
SG124283A1 (en) * 2004-03-24 2006-08-30 Trusted Hub Ltd Document signature method & system
ES2348920T3 (es) 2005-04-13 2010-12-17 Astion Development A/S Agonistas de adrenoceptores beta-2 para el tratamiento de enfermedades del tejido conectivo de la piel.
US20090181369A1 (en) * 2005-05-27 2009-07-16 George Q Daley Methods for the Treatment of Disease
US20090305225A1 (en) * 2005-06-13 2009-12-10 Galbraith Richard A Inhibition of Creatine Uptake to Promote Weight Loss
RU2408014C2 (ru) * 2009-03-10 2010-12-27 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет им. Н.И. Пирогова Министерства здравоохранения и социального развития Российской Федерации" Способ прогнозирования преждевременных родов инфекционного генеза
NZ707752A (en) 2012-12-03 2020-01-31 Pfizer Novel selective androgen receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136601C (cs) * 1967-06-15
US4119710A (en) * 1972-12-18 1978-10-10 Boehringer Ingelheim Gmbh Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts
US4407819A (en) * 1980-08-25 1983-10-04 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals
US4814350A (en) * 1986-09-10 1989-03-21 American Cyanamid Company Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)ethyl]anthranilonitrile
US4792546A (en) * 1986-12-05 1988-12-20 American Cyanamid Company Method for increasing weight gains and reducing deposition of fat in animals
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Also Published As

Publication number Publication date
US5395957A (en) 1995-03-07
FI109600B (fi) 2002-09-13
SG45439A1 (en) 1998-01-16
BG94342A (en) 1994-06-30
FI912151L (fi) 1991-11-05
HUT60999A (en) 1992-11-30
IL98030A0 (en) 1992-06-21
KR0183024B1 (ko) 1999-05-15
NO911746D0 (no) 1991-05-03
KR910019966A (ko) 1991-12-19
CA2041818C (en) 2003-02-11
ATE124932T1 (de) 1995-07-15
ES2109412T3 (es) 1998-01-16
US5648386A (en) 1997-07-15
AU645313B2 (en) 1994-01-13
CA2041818A1 (en) 1991-11-05
ES2075255T3 (es) 1995-10-01
NZ238032A (en) 1996-02-27
IL98030A (en) 1995-12-31
ATE158277T1 (de) 1997-10-15
ZA913337B (en) 1993-01-27
EP0589488A1 (de) 1994-03-30
DE4014252A1 (de) 1991-11-07
EP0589488B1 (de) 1997-09-17
JPH04225944A (ja) 1992-08-14
NO174803C (cs) 1994-07-13
EP0455155B1 (de) 1995-07-12
IE911507A1 (en) 1991-11-06
PT97544B (pt) 1998-08-31
DK0455155T3 (da) 1995-11-13
IE69017B1 (en) 1996-07-24
RU2002737C1 (ru) 1993-11-15
JP2944777B2 (ja) 1999-09-06
CZ286389B6 (cs) 2000-03-15
GR3025547T3 (en) 1998-03-31
US5248695A (en) 1993-09-28
HU214335B (hu) 1998-03-02
FI912151A0 (fi) 1991-05-03
ID966B (id) 1996-09-30
NO911746L (no) 1991-11-05
TW197415B (cs) 1993-01-01
CS129291A3 (en) 1991-11-12
DK0589488T3 (da) 1998-05-04
GR3017064T3 (en) 1995-11-30
EP0455155A1 (de) 1991-11-06
AR247728A1 (es) 1995-03-31
AU7611191A (en) 1991-11-07
NO174803B (no) 1994-04-05
DE59108853D1 (de) 1997-10-23
PT97544A (pt) 1992-01-31
SK279258B6 (sk) 1998-08-05
IE80651B1 (en) 1998-11-04
HU911502D0 (en) 1991-11-28
US5292753A (en) 1994-03-08
DE59105957D1 (de) 1995-08-17

Similar Documents

Publication Publication Date Title
BG60743B1 (bg) Енантомери,/-/-циматерол и техните лекарствени препарати или стимулатори и метод за отделяне на енантомери от циматерол
US5232946A (en) Phenylethanolamines, their use as pharmaceuticals and as performance enhancers in animals
DK171627B1 (da) Anvendelse af beta-phenethanolamin og farmaceutiskacceptable salte deraf samt dyrefoderpræblanding med indhold deraf
EP0026298A1 (en) Method for promoting growth and reducing fat in animals using phenylethanolamine derivatives
EP0103830A2 (de) Wachstumsfördernde Phenylethylamin-Derivate
JPS6152147B2 (cs)
JPS64949B2 (cs)
JP3164819B2 (ja) フェニルエタノールアミン類、これらの化合物を含有する医薬組成物及びそれらの製造方法
KR20020059730A (ko) 가축 생산성 개선을 위한 아릴옥시 프로판올아민
US5945455A (en) Amine and amidine containing compounds as weight reducing agents
US5621011A (en) [α-tert.butyl aminomethyl)-3,4-dichlorobenzyl] thioacetamide, a procedure for its preparation and its uses
FI78468B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 3,4,5-trihydroxipiperidinderivat.
AT376421B (de) Verfahren zur herstellung neuer 2-hydroxymethyl-3,4,5-trihydroxypiperidinderiva e
DE3636605A1 (de) Verfahren zur trennung der enantiomeren von 1-(4-amino-3,5-dichlorphenyl)-2-(tert.-butyl) -hydroxy-amino-ethanol sowie deren verwendung als leistungsfoerderer bei tieren
PT89147B (pt) Processo para a preparacao de novas feniletanolaminas e de composicoes farmaceuticas e de estimulantes de potencia ou de nutrientes para animais que as contem